Posted by Michael Wonder on 27 Sep 2017
AbbVie insists it’s keeping its pricing pledge, calling earlier reports ‘incorrect’
26 September 2017 - Stung by reports of backpedaling on a pledge to limit drug price hikes, AbbVie insisted on Tuesday that it will stick to just one, single-digit price increase next year.
The statement came a day after news reports — including ours — indicated the drug maker would abandon its commitment to keep all price increases below 10% and raise prices only once a year, although AbbVie maintained its pledge referred only to this year.
The original source for the stories was a report from a Wall Street securities analyst, who summarised AbbVie remarks following a meeting with company management last week.
